NEW YORK, Oct. 22, 2018 /PRNewswire/ -- About Bipolar DisorderBipolar disorder is also known as manic depression that causes extreme shifts in mood, energy, and activity levels. Elevated mood swings are called mania or hypomania, which differs based on the severity and presence of psychosis. Bipolar disorder is a long-lasting condition that can be categorized into bipolar I, bipolar II, and cyclothymia. This condition can be managed with a regular treatment. Insomnia, weight gain or loss, behavioral changes, and psychological imbalances are some of the symptoms witnessed in individuals with bipolar disorder.Read the full report: https://www.reportlinker.com/p04828786
Technavio's analysts forecast the Global Bipolar Disorder Therapeutics Market to grow at a CAGR of 2.38% during the period 2019-2023.Covered in this reportThe report covers the present scenario and the growth prospects of the bipolar disorder therapeutics market. To calculate the market size, the report considers the revenue generated from the application of bipolar disorder therapeutics across the globe.The market is divided into the following segments based on geography:• Americas• APAC• EMEATechnavio's report, bipolar disorder therapeutics market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendors• Allergan• AstraZeneca• Eli Lilly• GlaxoSmithKline• Johnson & JohnsonMarket driver• Growing prevalence of mental health disorders (MHDs) across the globe.• For a full, detailed list, view our reportMarket challenge• Lack of adequate diagnosis process• For a full, detailed list, view our reportMarket trend• Growing number of strategic alliances• For a full, detailed list, view our reportKey questions answered in this report• What will the market size be in 2023 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.Read the full report: https://www.reportlinker.com/p04828786
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/the-global-bipolar-disorder-therapeutics-market-is-forescasted-to-grow-at-a-cagr-of-2-38-during-the-period-2019-2023--300735295.html
SOURCE Reportlinker
